Hogy Medical Co.,Ltd. (HGYMF)
USD 24.34
(0.0%)
USD 24.34
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 2.8 Billion JPY | 8531.27% |
| 2023 | 32.48 Million JPY | -9.49% |
| 2022 | 35.89 Million JPY | -20.01% |
| 2021 | 44.86 Million JPY | -12.39% |
| 2020 | 51.21 Million JPY | -6.19% |
| 2019 | 54.59 Million JPY | 10.34% |
| 2018 | 49.47 Million JPY | -4.71% |
| 2017 | 51.92 Million JPY | -1.25% |
| 2016 | 52.58 Million JPY | -99.07% |
| 2015 | 5.65 Billion JPY | 0.48% |
| 2014 | 5.63 Billion JPY | 7.34% |
| 2013 | 5.24 Billion JPY | 13.47% |
| 2012 | 4.62 Billion JPY | 3.84% |
| 2011 | 4.45 Billion JPY | -9.51% |
| 2010 | 4.92 Billion JPY | 37.3% |
| 2009 | 3.58 Billion JPY | -11.61% |
| 2008 | 4.05 Billion JPY | 11.95% |
| 2007 | 3.62 Billion JPY | -7.36% |
| 2006 | 3.9 Billion JPY | 11.88% |
| 2005 | 3.49 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | 195 Million JPY | 3037.42% |
| 2024 FY | 2.8 Billion JPY | 8531.27% |
| 2024 Q1 | 6.13 Million JPY | 34.2% |
| 2024 Q2 | 5.66 Million JPY | -7.55% |
| 2024 Q3 | 6.21 Million JPY | 9.65% |
| 2023 Q4 | 4.56 Million JPY | -59.43% |
| 2023 Q1 | 9.59 Million JPY | 72.53% |
| 2023 FY | 32.48 Million JPY | -9.49% |
| 2023 Q3 | 11.26 Million JPY | 75.49% |
| 2023 Q2 | 6.41 Million JPY | -33.13% |
| 2022 Q4 | 5.56 Million JPY | -56.11% |
| 2022 Q3 | 12.67 Million JPY | 23.2% |
| 2022 FY | 35.89 Million JPY | -20.01% |
| 2022 Q1 | 9.8 Million JPY | -98.52% |
| 2022 Q2 | 10.28 Million JPY | 4.94% |
| 2021 Q2 | 1.86 Billion JPY | 105.73% |
| 2021 Q1 | 908 Million JPY | -4.72% |
| 2021 Q3 | 1.52 Billion JPY | -18.63% |
| 2021 FY | 44.86 Million JPY | -12.39% |
| 2021 Q4 | 663 Million JPY | -56.38% |
| 2020 Q3 | 1.31 Billion JPY | -42.47% |
| 2020 FY | 51.21 Million JPY | -6.19% |
| 2020 Q1 | 986 Million JPY | 137.59% |
| 2020 Q4 | 953 Million JPY | -27.31% |
| 2020 Q2 | 2.27 Billion JPY | 131.14% |
| 2019 FY | 54.59 Million JPY | 10.34% |
| 2019 Q1 | 898 Million JPY | 34.43% |
| 2019 Q2 | 3.63 Billion JPY | 304.9% |
| 2019 Q3 | 1.09 Billion JPY | -69.91% |
| 2019 Q4 | 415 Million JPY | -62.07% |
| 2018 Q4 | 668 Million JPY | -33.73% |
| 2018 Q3 | 1 Billion JPY | 2.86% |
| 2018 Q2 | 980 Million JPY | -62.39% |
| 2018 Q1 | 2.6 Billion JPY | 152.03% |
| 2018 FY | 49.47 Million JPY | -4.71% |
| 2017 FY | 51.92 Million JPY | -1.25% |
| 2017 Q2 | 1.25 Billion JPY | -11.97% |
| 2017 Q1 | 1.42 Billion JPY | 5.47% |
| 2017 Q3 | 2.06 Billion JPY | 64.44% |
| 2017 Q4 | 1.03 Billion JPY | -49.98% |
| 2016 Q2 | 1.54 Billion JPY | 3.55% |
| 2016 FY | 52.58 Million JPY | -99.07% |
| 2016 Q3 | 1.52 Billion JPY | -1.49% |
| 2016 Q4 | 1.35 Billion JPY | -10.98% |
| 2016 Q1 | 1.49 Billion JPY | 22.82% |
| 2015 Q2 | 1.47 Billion JPY | 12.0% |
| 2015 Q1 | 1.31 Billion JPY | 25.43% |
| 2015 Q3 | 1.65 Billion JPY | 12.07% |
| 2015 FY | 5.65 Billion JPY | 0.48% |
| 2015 Q4 | 1.21 Billion JPY | -26.56% |
| 2014 Q4 | 1.05 Billion JPY | -41.01% |
| 2014 FY | 5.63 Billion JPY | 7.34% |
| 2014 Q3 | 1.78 Billion JPY | 24.74% |
| 2014 Q2 | 1.42 Billion JPY | 3.78% |
| 2014 Q1 | 1.37 Billion JPY | 23.32% |
| 2013 FY | 5.24 Billion JPY | 13.47% |
| 2013 Q3 | 1.61 Billion JPY | 28.53% |
| 2013 Q4 | 1.11 Billion JPY | -30.87% |
| 2013 Q1 | 1.26 Billion JPY | 26.78% |
| 2013 Q2 | 1.25 Billion JPY | -0.71% |
| 2012 Q3 | 1.25 Billion JPY | 19.92% |
| 2012 FY | 4.62 Billion JPY | 3.84% |
| 2012 Q1 | 1.32 Billion JPY | 157.31% |
| 2012 Q4 | 997 Million JPY | -20.75% |
| 2012 Q2 | 1.04 Billion JPY | -20.53% |
| 2011 Q2 | 1.25 Billion JPY | -0.24% |
| 2011 Q3 | 1.42 Billion JPY | 13.13% |
| 2011 FY | 4.45 Billion JPY | -9.51% |
| 2011 Q1 | 1.26 Billion JPY | 16.13% |
| 2011 Q4 | 513 Million JPY | -63.92% |
| 2010 Q1 | 1.18 Billion JPY | 51.33% |
| 2010 Q3 | 1.45 Billion JPY | 22.3% |
| 2010 Q2 | 1.19 Billion JPY | 0.85% |
| 2010 FY | 4.92 Billion JPY | 37.3% |
| 2010 Q4 | 1.08 Billion JPY | -25.63% |
| 2009 Q2 | 1.22 Billion JPY | 0.0% |
| 2009 FY | 3.58 Billion JPY | -11.61% |
| 2009 Q3 | 507 Million JPY | -58.68% |
| 2009 Q4 | 781.74 Million JPY | 54.19% |
| 2008 FY | 4.05 Billion JPY | 11.95% |
| 2007 FY | 3.62 Billion JPY | -7.36% |
| 2006 FY | 3.9 Billion JPY | 11.88% |
| 2005 FY | 3.49 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 302616.04% |
| Ansell Limited | 76.5 Million USD | -3565.359% |
| Ansell Limited | 76.5 Million USD | -3565.359% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 24.28 Million USD | -11448.505% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 172098.898% |
| Psykey, Inc. | -1.32 Million USD | 211890.316% |
| ConvaTec Group Plc | 130.3 Million USD | -2051.957% |
| ConvaTec Group Plc | 130.3 Million USD | -2051.957% |
| Encision Inc. | -691.78 Thousand USD | 405429.417% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 1977379.619% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 1196519.276% |
| Innovative MedTech Inc. | -7.93 Million USD | 35419.768% |
| LifePoint, Inc. | -15.23 Million USD | 18509.101% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 41268.698% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 591661.181% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 1021794.614% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 610955.983% |
| SmileDirectClub, Inc. | -86.4 Million USD | 3345.22% |
| Sector 10, Inc. | 7036.00 USD | -39852088.744% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | -40.067% |
| SheerVision, Inc. | -71.37 Thousand USD | 3928591.37% |
| United Health Products, Inc. | -2.62 Million USD | 106989.615% |
| Vasamed, Inc. | -4.88 Million USD | 57463.18% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 117497.477% |
| Yubo International Biotech Limited | -1.2 Million USD | 232842.485% |